This position paper supersedes the 2022 WHO position paper on malaria vaccines. It includes the updated WHO recommendations on the use of the RTS,S/AS01 and R21/Matrix-M vaccines for the reduction of malar...ia morbidity and mortality in children living in endemic areas, prioritizing areas of moderate and high malaria transmission.
more
Due to the heterogeneous distribution of malaria transmission and its determinants, subnational tailoring (SNT) provides an analytical framework to facilitate the targeting of each population with appropriate intervention packages for maximum impact... to inform national strategic planning and prioritization based on resources available. The WHO Global Malaria Programme recommends the use of subnational data on disease epidemiology and other relevant local contextual factors to facilitate the process of SNT. Once the strategies and intervention mixes have been defined, programmes can proceed to the prioritization of
interventions for effective programming, based on available resources
more
Rivercess, Liberia, April 25, 2024 - Liberia marks a monumental milestone in its battle against malaria
as it launches the highly anticipated RTS,S malaria vaccine today, coinciding with World ...n class="attribute-to-highlight medbox">Malaria Day,
commemorated under the theme: Health Equity, Gender, and Human Rights: Accelerating the Fight
Against Malaria for a More Equitable World. The launch ceremony, held in Rivercess County, signals a
significant step forward in the nation's commitment to safeguarding the health of its children and
communities.
more
The Mekong Malaria Elimination (MME) programme is an initiative aimed at supporting Greater Mekong Subregion (GMS) countries – Cambodia, Lao People's Democratic Republic, Myanmar, Thailand, Viet Nam, and Yunnan (China) – in achieving the goal of... malaria elimination by 2030. Data for this epidemiological summary were compiled from country reports. Between January and March 2024, 22 632 malaria cases were reported. During that period, GMS countries recorded 28% fewer cases, with P. falciparum + mixed and P. vivax cases declining by 50% and 23%, respectively. Meanwhile, testing declined by 21% when compared to the same period in 2023.
more
Accessed 18 February 2015
Fighting malaria and Saving Lives, Accessed Febr. 23, 2017